GeneReach Biotechnology (4171) — Net Asset Quality Index
GeneReach Biotechnology (4171) has a Net Asset Quality Index of 67.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$858.12 Million minus total liabilities of NT$276.64 Million yields net assets of NT$581.48 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read GeneReach Biotechnology total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
GeneReach Biotechnology Net Asset Quality Index Over Time (2017–2025)
This chart shows how GeneReach Biotechnology's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the index stands at 67.8%, representing net assets of NT$581.48 Million against total assets of NT$858.12 Million TWD. For live market cap and overall valuation, see market value of GeneReach Biotechnology.
Annual Net Asset Quality Index for GeneReach Biotechnology (2017–2025)
The table below presents the year-by-year Net Asset Quality Index for GeneReach Biotechnology from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 4171 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 67.7% | NT$596.72 Million | NT$881.05 Million | NT$284.34 Million | ▼ -0.3 pp |
| 2024 | 68.0% | NT$725.49 Million | NT$1.07 Billion | NT$341.00 Million | ▼ -5.3 pp |
| 2023 | 73.3% | NT$862.44 Million | NT$1.18 Billion | NT$313.71 Million | ▲ +5.3 pp |
| 2022 | 68.0% | NT$1.10 Billion | NT$1.62 Billion | NT$519.23 Million | ▲ +3.4 pp |
| 2021 | 64.6% | NT$1.09 Billion | NT$1.68 Billion | NT$596.35 Million | ▼ -4.5 pp |
| 2020 | 69.1% | NT$857.76 Million | NT$1.24 Billion | NT$382.75 Million | ▼ -8.8 pp |
| 2019 | 77.9% | NT$593.05 Million | NT$760.87 Million | NT$167.82 Million | ▲ +33.1 pp |
| 2018 | 44.8% | NT$311.15 Million | NT$693.83 Million | NT$382.68 Million | ▲ +3.3 pp |
| 2017 | 41.6% | NT$250.63 Million | NT$602.84 Million | NT$352.21 Million | — |